Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Ocular Therapeutix, Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
+9 vs. Q1 2023
Shares held
43.5M
+2.97M (+7.3%) vs. Q1 2023
Total value
$224.2M
+$10.4M (+4.9%) vs. Q1 2023
New holders
26
42 more added
Sold out
17
38 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 135 institutions
Q1 2021: 154 institutionsQ2 2021: 149 institutionsQ3 2021: 141 institutionsQ4 2021: 140 institutionsQ1 2022: 132 institutionsQ2 2022: 123 institutionsQ3 2022: 130 institutionsQ4 2022: 116 institutionsQ1 2023: 127 institutionsQ2 2023: 135 institutionsQ3 2023: 114 institutionsQ4 2023: 119 institutionsQ1 2024: 147 institutionsQ2 2024: 151 institutionsQ3 2024: 168 institutionsQ4 2024: 180 institutionsQ1 2025: 197 institutionsQ2 2025: 187 institutionsQ3 2025: 216 institutionsQ4 2025: 249 institutionsQ1 2026: 271 institutionsQ2 2026: 262 institutions
Value heldQ2 2023: $224.2M
Q1 2021: $774.9MQ2 2021: $685.8MQ3 2021: $445.7MQ4 2021: $289.1MQ1 2022: $215.4MQ2 2022: $178.2MQ3 2022: $177.6MQ4 2022: $111.3MQ1 2023: $213.8MQ2 2023: $224.2MQ3 2023: $127.0MQ4 2023: $328.8MQ1 2024: $1.12BQ2 2024: $939.8MQ3 2024: $1.22BQ4 2024: $1.14BQ1 2025: $1.01BQ2 2025: $1.45BQ3 2025: $2.20BQ4 2025: $2.33BQ1 2026: $1.77BQ2 2026: $2.03B
Institutions holding OCUL and their total value by quarter
QuarterHoldersValue
Q2 2026262$2.03B
Q1 2026271$1.77B
Q4 2025249$2.33B
Q3 2025216$2.20B
Q2 2025187$1.45B
Q1 2025197$1.01B
Q4 2024180$1.14B
Q3 2024168$1.22B
Q2 2024151$939.8M
Q1 2024147$1.12B
Q4 2023119$328.8M
Q3 2023114$127.0M
Q2 2023135$224.2M
Q1 2023127$213.8M
Q4 2022116$111.3M
Q3 2022130$177.6M
Q2 2022123$178.2M
Q1 2022132$215.4M
Q4 2021140$289.1M
Q3 2021141$445.7M
Q2 2021149$685.8M
Q1 2021154$774.9M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q1 2023.

Institutions holding OCUL in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Invesco Ltd.178,549$921.3K0.00%+9,397+5.6%Added
Bank of Montreal181,509$936.6K0.00%+181,509New
Nottingham Advisors, Inc.194,266$1.00M0.13%00.0%Unchanged
Knoll Capital Management, LLC200,000$1.03M1.26%00.0%Unchanged
Tudor Investment Corp Et Al200,843$1.04M0.02%+132,459+193.7%Added
Goldman Sachs Group Inc207,492$1.07M0.00%+26,827+14.8%Added
Charles Schwab Investment Management Inc214,415$1.11M0.00%+8,166+4.0%Added
Jump Financial, LLC220,300$1.14M0.04%+108,300+96.7%Added
Morgan Stanley232,765$1.20M0.00%−948,938−80.3%Reduced
Jane Street Group, LLC257,268$1.33M0.00%+140,222+119.8%Added
Lynwood Capital Management Inc.262,500$1.35M1.72%+262,500New
Wellington Management Group LLP280,874$1.45M0.00%−26,234−8.5%Reduced
Bank of New York Mellon Corp293,412$1.51M0.00%+3,357+1.2%Added
Essex Investment Management Co LLC300,977$1.55M0.22%+300,977New
UBS Oconnor LLC302,111$1.56M0.03%−61,175−16.8%Reduced
Two Sigma Advisers, LP354,200$1.83M0.00%+44,800+14.5%Added
Endurant Capital Management LP368,438$1.90M2.45%−144,306−28.1%Reduced
Susquehanna International Group, LLP375,601$1.94M0.00%+131,022+53.6%Added
Banco Santander, S.A.397,443$2.05M0.03%+129,554+48.4%Added
AXA S.A.474,900$2.45M0.01%+474,900New
Cetera Investment Advisers611,250$3.15M0.03%+10,100+1.7%Added
Cormorant Asset Management, LP645,000$3.33M0.19%+645,000New
D. E. Shaw & Co., Inc.656,105$3.39M0.01%−443,665−40.3%Reduced
Northern Trust Corp662,510$3.42M0.00%+5,413+0.8%Added
Sectoral Asset Management Inc802,680$4.14M0.69%+802,680New
Nuveen Asset Management, LLC919,602$4.75M0.00%+726,569+376.4%Added
Citadel Advisors LLC1,249,751$6.45M0.01%−276,521−18.1%Reduced
Geode Capital Management, LLC1,569,904$8.10M0.00%+112,164+7.7%Added
State Street Corp1,576,213$8.13M0.00%+83,254+5.6%Added
Deltec Asset Management LLC1,974,797$10.2M2.23%+61,185+3.2%Added
Millennium Management LLC2,396,840$12.4M0.01%+1,360,285+131.2%Added
Vanguard Group Inc4,052,827$20.9M0.00%+11,437+0.3%Added
BlackRock Inc.5,262,920$27.2M0.00%+344,611+7.0%Added
Opaleye Management Inc.5,780,000$29.8M7.13%−325,900−5.3%Reduced
Summer Road LLC6,122,089$31.6M100.00%00.0%Unchanged
EAM Investors, LLC0$00.00%−224,211−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−77,661−100.0%Sold out
Tejara Capital Ltd0$00.00%−72,457−100.0%Sold out
PDT Partners, LLC0$00.00%−65,350−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−42,989−100.0%Sold out
Group One Trading, L.P.0$00.00%−39,742−100.0%Sold out
SG Americas Securities, LLC0$00.00%−33,849−100.0%Sold out
Axq Capital, LP0$00.00%−25,972−100.0%Sold out
Ergoteles LLC0$00.00%−20,145−100.0%Sold out
Creative Planning0$00.00%−13,889−100.0%Sold out
Quantamental Technologies LLC0$00.00%−13,331−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−12,550−100.0%Sold out
Quantbot Technologies LP0$00.00%−3,254−100.0%Sold out
Fifth Third Bancorp0$00.00%−500−100.0%Sold out
Advisory Services Network, LLC0$00.00%−250−100.0%Sold out
Signaturefd, LLC0$00.00%−192−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−100−100.0%Sold out
Ahrens Investment Partners LLC––––Not filed